{
  "id": "CritAssess278",
  "type": "CriterionAssessment",
  "criterion": {
    "id": "Crit304",
    "type": "Criterion",
    "label": "PS1",
    "description": "Same amino acid change as a previously established pathogenic variant regardless of nucleotide change",
    "defaultStrength": {
      "id": "ELSID145",
      "type": "EvidenceLineStrength",
      "label": "Pathogenic Strong"
    },
    "comments": "Beware of changes that impact splicing rather than at the amino acid/protein level\nFrom CSER paper: One site erroneously used this to apply prior publication of the same exact variant while this rule, as described in more depth on the ACMG/AMP guideline, only applies when the established pathogenic variant has a different nucleotide change than the variant being interpreted."
  },
  "variant": {
    "id": "CanAll004",
    "type": "CanonicalAllele",
    "preferredCtxAllele": {
      "id": "CtxAll005",
      "type": "ContextualAllele",
      "producedBy": null,
      "relatedCanonicalAllele": "CanAll004",
      "alleleName": "NM_002834.3(PTPN11):c.855T>G (p.Phe285Leu)",
      "produces": [
        {
          "id": "CtxAll007",
          "type": "ContextualAllele",
          "producedBy": "CtxAll006",
          "relatedCanonicalAllele": "CanAll006",
          "alleleName": "NP_002825.3:p.Phe285Leu"
        }
      ]
    }
  },
  "condition": [
    {
      "id": "GenCond003",
      "type": "GeneticCondition",
      "disease": [
        {
          "id": "DisID175",
          "type": "Disease",
          "label": "noonan syndrome"
        }
      ],
      "modeOfInheritance": {
        "id": "MOIID051",
        "type": "ModeOfInheritance",
        "label": "Autosomal Dominant"
      }
    }
  ],
  "outcome": {
    "id": "CEID074",
    "type": "CriterionEvaluation",
    "label": "Met"
  },
  "evidenceLine": [
    {
      "id": "EvLn005",
      "type": "EvidenceLine",
      "evidenceItem": [
        {
          "id": "VarInterp008",
          "type": "VariantInterpretation",
          "variant": {
            "id": "CanAll005",
            "type": "CanonicalAllele",
            "preferredCtxAllele": {
              "id": "CtxAll006",
              "type": "ContextualAllele",
              "producedBy": null,
              "relatedCanonicalAllele": "CanAll005",
              "alleleName": "NM_002834.3(PTPN11):c.853T>C (p.Phe285Leu)",
              "produces": [
                {
                  "id": "CtxAll007",
                  "type": "ContextualAllele",
                  "producedBy": "CtxAll006",
                  "relatedCanonicalAllele": "CanAll006",
                  "alleleName": "NP_002825.3:p.Phe285Leu"
                }
              ]
            }
          },
          "condition": [
            {
              "id": "GenCond003",
              "type": "GeneticCondition",
              "disease": [
                {
                  "id": "DisID175",
                  "type": "Disease",
                  "label": "noonan syndrome"
                }
              ],
              "modeOfInheritance": {
                "id": "MOIID051",
                "type": "ModeOfInheritance",
                "label": "Autosomal Dominant"
              }
            }
          ],
          "outcome": {
            "id": "SIGID031",
            "type": "Significance",
            "label": "Pathogenic"
          },
          "description": "NM_002834.3:c.855T>G Pathogenic for Noonan Syndrome"
        }
      ]
    }
  ],
  "contribution": [
    {
      "type": "Contribution",
      "agent": {
        "id": "Agent001",
        "type": "Agent",
        "label": "Harry Stevenson"
      },
      "contributionDate": "6/2/16 3:22 PM",
      "contributionRole": {
        "id": "CRID193",
        "type": "ContributoryRole",
        "label": "assessor role"
      }
    }
  ],
  "description": "The assessed variant produces the same amino acid change (p.Phe285Leu) as known pathogenic variant c.853T>C"
}
